María Mora, Ana Gallén, Ana Garayoa, Mercedes Jaén, José Gonzalvo, Héctor Tomás, Noelia Sancho, Samuel Díaz, Rubén Cuesta, José Ramón Molés, Francisco Grau, Beatriz Antequera, Ana Reyes Liebana, Xavier Cortés-Rizo, Michel Colmenares, Marina Ynfante, Iulia Alexandra, Angela Nicolás, Vanesa Martín-Carbonell, Lucia Belloch, Lucia Redondo-Cuevas, Nadia Moreno, Laura Sanchis, Ernesto Cortés-Castell, Eva Sánchez
Journal: Nutrients 2024;16(7):
PMID: 38613116
Small intestinal bacterial overgrowth (SIBO) arises from dysbiosis in the small intestine, manifesting with abdominal symptoms. This study aims to assess the efficacy of combined antibiotic therapy, herbal supplements, probiotics, and dietary modifications in SIBO management. A total of 179 SIBO-diagnosed patients underwent clinical evaluation and breath testing. Patients were categorized into hydrogen (H-SIBO) and methane (CH-SIBO) groups. The control group received standard antibiotic therapy and a low-FODMAP diet, while the intervention group received additional herbal antibiotics, probiotics, and prebiotics. After treatment, both groups exhibited reduced gas levels, particularly in CH-SIBO. Clinical remission rates were higher in the intervention group, especially in CH-SIBO cases. Logistic regression analysis showed gas concentrations at diagnosis as significant predictors of treatment success. In conclusion, adjunctive herbal supplements and probiotics did not significantly impact gas levels, but showed potential for clinical improvement, especially in CH-SIBO.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.